IP Library Granted Patent US 10,154,831
Granted Patent B2
US 10,154,831 · App. 15/669,675 · Granted Dec 18, 2018

Methods for imaging and ablating body tissue

Inventors: Hira V. Thapliyal (Los Altos, CA); David A. Gallup (Alameda, CA); James W. Arenson (Woodside, CA); John Paul Mohr, III (Aptos, CA); Tim Proulx (Santa Cruz, CA); Robert A. Brommer (Fremont, CA)
Assignee: VytronUS, Inc.
A61B8/4494A61B8/0883A61B8/12A61B8/445A61B17/320068A61N7/022A61B2017/320069A61B2018/00023A61B2090/3782
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,154,831
App. No.
15/669,675
Granted
Dec 18, 2018
Kind
B2
Abstract

A method for creating a transmural lesion in tissue includes positioning a distal portion of a catheter near the tissue, where an ultrasound transducer is attached to the distal portion and is operatively coupled to a console and processor. The tissue is imaged by energizing the ultrasound transducer at a first power level to produce an ultrasound beam, where the imaging determines a thickness of the tissue, and a gap distance between the ultrasound transducer and the tissue. The tissue is ablated by energizing the ultrasound transducer at a second power level to produce the ultrasound beam. Energy delivered to the tissue during the ablating is controlled, using the processor, where the processor adjusts a speed of the ultrasound beam moving across the tissue based on the thickness and gap distance, to create the transmural lesion.

Claims (25)

1. A method for creating a transmural lesion in tissue, the method comprising:

positioning a distal portion of a catheter near the tissue, wherein an ultrasound transducer is attached to the distal portion and is operatively coupled to a console and processor;

imaging the tissue by energizing the ultrasound transducer at a first power level to produce an ultrasound beam, wherein the imaging determines a thickness of the tissue, and a gap distance between the ultrasound transducer and the tissue;

ablating the tissue by energizing the ultrasound transducer at a second power level to produce the ultrasound beam; and

controlling energy delivered to the tissue during the ablating, using the processor, wherein the processor adjusts a speed of the ultrasound beam moving across the tissue based on the thickness and gap distance, to create the transmural lesion.

2. The method of claim 1 , wherein the ultrasound transducer is energized at a first frequency level during the imaging and a second frequency level while ablating.

3. The method of claim 1 , wherein there is no direct contact between the ultrasound transducer and the tissue during imaging or the ablating.

4. The method of claim 1 , wherein the transmural lesion has a tear drop shape.

5. The method of claim 1 , wherein during the ablating, the transmural lesion is created while an outer layer of tissue remains substantially undamaged.

6. The method of claim 1 , wherein during the ablating, the transmural lesion is created while an endocardial surface of the tissue remains uncharred.

7. The method of claim 1 , wherein the ultrasound transducer comprises a single, flat transducer element.

8. The method of claim 7 , wherein the ultrasound transducer comprises an inactive portion surrounded by an active portion.

9. The method of claim 7 , wherein a heat sink is attached to the ultrasound transducer.

10. The method of claim 7 , wherein a matching layer is coupled to the ultrasound transducer.

11. The method of claim 1 , wherein the processor further adjusts a catheter position to maintain a preferred value for the gap distance during the ablating.

12. The method of claim 1 , wherein the processor further adjusts a catheter position to achieve a preset depth for the transmural lesion.

13. The method of claim 1 , wherein the processor indicates to an operator to reposition the catheter for the ablating.

14. The method of claim 1 , further comprising supplying a cooling fluid in fluid communication with the ultrasound transducer.

15. The method of claim 14 , wherein a temperature sensor is coupled to the ultrasound transducer for monitoring temperature of the ultrasound transducer.

16. The method of claim 14 , wherein the processor controls flow of the cooling fluid to maintain a temperature of the ultrasound transducer within a desired operating range.

17. The method of claim 14 , wherein the processor controls flow of the cooling fluid based on detected characteristics of the tissue.

18. The method of claim 1 , wherein the processor, based on the thickness and the gap distance, controls the ultrasound beam by modifying an electrical signal sent to the ultrasound transducer.

19. The method of claim 1 , wherein the processor uses the speed, the energy delivered, and a beamwidth of the ultrasound beam to deliver a desired energy density to the tissue.

20. The method of claim 1 , wherein the imaging further comprises determining an incident beam angle, and the incident beam angle is used to determine the speed of the ultrasound beam during ablation.

21. The method of claim 1 , wherein the second power level is different from the first power level.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2020
From: VYTRONUS, INC.
To: AURIS HEALTH, INC.
Reel/Frame 052878/0942 →
Continuity (4)
Continuation 13907412 · May 31, 2013
Continuation 12620287 · Nov 17, 2009
Provisional Application 61115403 · Nov 17, 2008
Related Publication 20170354397A1 · Dec 14, 2017